← Leaderboards
Zhonglin Xie
University Of Oklahoma Hlth Sciences Ctr
$6,976,924
Attributed
$13,088,682
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2008–22$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$13,088,682 · 9
By mechanism
R01$12,223,516 · 5
P20$865,166 · 4
Top collaborators
- Ming-Hui Zou16 shared
- Hongyu Qiu2 shared
Most similar at University Of Oklahoma Hlth Sciences Ctr
Same institution · by research overlap
- Robert D Foreman$3,046,568
- Lu Zhong-Lin$239,456
Others in their field
Top investigators on “Animal Model”
- David Heimbrook · Leidos Biomedical Research, Inc.$464,525,875
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Joseph E Robertson · Oregon Health & Science University$126,125,279
- Peter Gordon Gillespie · Oregon Health And Science University$105,808,119
- David M Anderson · University Of Washington$102,920,737
- Polly Chang · Sri International$84,271,267
Research focus
Animal ModelInsightPreventIn VivoMediatingOverexpressionProteinsDiabetes MellitusLoss Of FunctionPathway InteractionsMolecularCardiac MyocytesHeartCardiacDiabeticSourceVascular DiseasesEventCultured CellsImpairmentMouse ModelSignal TransductionKnock-OutMitochondria
Grant awards (22)
SNRK in ischemic vascular diseases$744,503
R01 · FY2022 · HL · contact PI
SNRK in ischemic vascular diseases$744,503
R01 · FY2021 · HL · contact PI
Role of VCP in coronary ischemic injury$634,190
R01 · FY2021 · HL
FUNDC1 and diabetic cardiomyopathy$705,028
R01 · FY2020 · HL · contact PI
Role of VCP in coronary ischemic injury$637,125
R01 · FY2020 · HL
SNRK in ischemic vascular diseases$744,503
R01 · FY2019 · HL · contact PI
FUNDC1 and diabetic cardiomyopathy$705,028
R01 · FY2019 · HL · contact PI
Autophagy and VSMC migration$675,620
R01 · FY2019 · HL · contact PI
SNRK in ischemic vascular diseases$744,503
R01 · FY2018 · HL · contact PI
FUNDC1 and diabetic cardiomyopathy$705,028
R01 · FY2018 · HL · contact PI
Autophagy and VSMC migration$675,620
R01 · FY2018 · HL · contact PI
Suppression of Autophagy-Dependent Clearance Mitochondria in Type 2 Diabetes$616,466
R01 · FY2018 · HL · contact PI
FUNDC1 and diabetic cardiomyopathy$705,028
R01 · FY2017 · HL · contact PI
Autophagy and VSMC migration$675,620
R01 · FY2017 · HL · contact PI
Suppression of Autophagy-Dependent Clearance Mitochondria in Type 2 Diabetes$616,466
R01 · FY2017 · HL · contact PI
Autophagy and VSMC migration$678,987
R01 · FY2016 · HL · contact PI
Suppression of Autophagy-Dependent Clearance Mitochondria in Type 2 Diabetes$613,074
R01 · FY2016 · HL · contact PI
Suppression of Autophagy-Dependent Clearance Mitochondria in Type 2 Diabetes$602,224
R01 · FY2015 · HL · contact PI
OKHSC COBRE: ACTIVATION OF AMPK PROTECTS AGAINST DIABETIC VASCULAR COMPLICATIONS$212,534
P20 · FY2011 · RR · contact PI
OKHSC COBRE: ACTIVATION OF AMPK PROTECTS AGAINST DIABETIC VASCULAR COMPLICATIONS$214,787
P20 · FY2010 · RR · contact PI
OKHSC COBRE: ACTIVATION OF AMPK PROTECTS AGAINST DIABETIC VASCULAR COMPLICATIONS$225,194
P20 · FY2009 · RR · contact PI
OKHSC COBRE: ACTIVATION OF AMPK PROTECTS AGAINST DIABETIC VASCULAR COMPLICATIONS$212,651
P20 · FY2008 · RR · contact PI